Activation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings

Cited 43 time in scopus
Metadata Downloads

Full metadata record

DC FieldValueLanguage
dc.contributor.authorSuk Mi Kang-Park-
dc.contributor.authorJe Ho Lee-
dc.contributor.authorJeh Hoon Shin-
dc.contributor.authorYoung Ik Lee-
dc.date.accessioned2017-04-19T08:57:55Z-
dc.date.available2017-04-19T08:57:55Z-
dc.date.issued2001-
dc.identifier.issn0006-291X-
dc.identifier.uri10.1006/bbrc.2001.4767ko
dc.identifier.urihttps://oak.kribb.re.kr/handle/201005/5445-
dc.description.abstractWe have recently shown that HBx protein, one of the causative agents of hepatocellular carcinomas, regulates Sp1 mediated transcription of insulin-like growth factor II promoter 4 (Lee et al. (1998) Oncogene 16, 2367-2380). Here we show that PKC and p44/p42MAPK signalings are required for the HBx-induced Sp1-mediated IGF-II P4 transcriptional activity since (i) PKC activation by PMA or PKC expression vector increases Sp1 phosphorylation and P4 activity in HBx-transfected HepG2 cells; (ii) PKC inhibition by PKC inhibitor G?6976 reduces Spl phosphorylation, P4 activity, and IGF-II mRNA in HBx-transfected HepG2 cells; and (iii) the inhibition of MEK activation by U0126 reduces Sp1 phosphorylation, P4 activity and IGF-II mRNA in HBx-transfected HepG2 cells. These results demonstrate that PKC and p44/p42 MAPK cascades are the essential signaling pathways in Sp1-mediated IGF-II gene activation by HBx.-
dc.publisherElsevier-
dc.titleActivation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings-
dc.title.alternativeActivation of the IGF-II Gene by HBV-X Protein Requires PKC and p44/p42 Map Kinase Signalings-
dc.typeArticle-
dc.citation.titleBiochemical and Biophysical Research Communications-
dc.citation.number2-
dc.citation.endPage307-
dc.citation.startPage303-
dc.citation.volume283-
dc.contributor.affiliatedAuthorSuk Mi Kang-Park-
dc.contributor.affiliatedAuthorYoung Ik Lee-
dc.contributor.alternativeName박숙미-
dc.contributor.alternativeName이제호-
dc.contributor.alternativeName신재훈-
dc.contributor.alternativeName이영익-
dc.identifier.bibliographicCitationBiochemical and Biophysical Research Communications, vol. 283, no. 2, pp. 303-307-
dc.identifier.doi10.1006/bbrc.2001.4767-
dc.subject.keywordHBV-X-
dc.subject.keywordHepatocellular carcinomas-
dc.subject.keywordIGF-II-
dc.subject.keywordMAPK-
dc.subject.keywordPhosphorylation-
dc.subject.keywordPKC-
dc.subject.keywordSp1-
dc.subject.localHBV-X-
dc.subject.localHepatocellular carcinoma-
dc.subject.localHepatocellular carcinoma (HCC)-
dc.subject.localHepatocellular carcinomas-
dc.subject.localhepatocellular carcinoma-
dc.subject.localhepatocellular carcinoma (HCC)-
dc.subject.localIGF-II-
dc.subject.localMAPK-
dc.subject.localMAPKs-
dc.subject.localPhosphorylation-
dc.subject.localphosphorylation-
dc.subject.localPKC-
dc.subject.localSP-1-
dc.subject.localSP1-
dc.subject.localSp1-
dc.description.journalClassY-
Appears in Collections:
1. Journal Articles > Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.